Terapia Intensiva
Destaques de diretriz clínica para o hospitalista | Tratamento do sangramento gastrintestinal alto e úlcera.
22 Nov, 2021 | 09:13hClinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding – Journal of Hospital Medicine (gratuito por tempo limitado)
Estudo RECOVERY | Aspirina como terapia complementar não reduziu a mortalidade em pacientes internados com COVID-19.
19 Nov, 2021 | 13:20hComentário convidado: Studying the coagulopathy of COVID-19 – The Lancet
Comentário do autor no Twitter (fio – clique para saber mais)
RECOVERY Publication: ASPIRIN
(a widely used anti-platelet treatment in other settings)14 892 patients hospitalised with COVID-19.
No impact on mortality.
Small improvement in hospital stay.
No impact on need for mechanical ventilation
6 more bleeds. 6 fewer thromboses (clots) pic.twitter.com/LxDzudss9F— Martin Landray (@MartinLandray) November 18, 2021
Recomendações de consenso de especialistas | Habilidades básicas de ultrassonografia para intensivistas na terapia intensiva geral e neurológica.
19 Nov, 2021 | 13:05h
Comentário no Twitter
Basic #ultrasound skills in #ICU & NCCU, @ESICM consensus & expert recommendations:
➡️brain
➡️lung
➡️heart
➡️abdomen
➡️vascular#FOAMcc #FOAMus #echofirst #POCUS
🖇️https://t.co/T1IuLlsomS
DO NOT miss supplementary files including additional figures & links to video description! pic.twitter.com/kbuIvuHvGI— Intens Care Med (@yourICM) November 17, 2021
[Preprint] M-A | Corticosteroides inalatórios em pacientes ambulatoriais com COVID-19.
19 Nov, 2021 | 12:29hInhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis – medRxiv
Comentário: Favourable meta-analysis of inhaled corticosteroids in COVID-19 outpatients – News Medical
Conteúdos relacionados:
Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.
RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19
Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19
Comentário no Twitter
The first meta-analysis of the 4 completed & reported trials of outpatient inhaled corticosteroid #COVID19 treatment
The results support the use of inhaled corticosteroids (ciclesonide or budesonide) for the resolution of symptoms at day 14 of treatmenthttps://t.co/KnBDKhfYmi pic.twitter.com/WSd9htXwe4— Antibiotic Stewa®️x🆔 Bassam Ghanem (@ABsteward) November 5, 2021
Editorial | 20 recomendações para individualizar intervenções na ressuscitação precoce de pacientes com sepse.
19 Nov, 2021 | 12:20hConteúdo relacionado: Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
Desmistificando o relatório de EEG para intensivistas.
19 Nov, 2021 | 12:19hDemystifying the EEG Report – NeuroEMCrit
Estudo randomizado | Imunoglobulinas intravenosas não melhoram os desfechos em pacientes com síndrome da angústia respiratória aguda moderada a grave associada a COVID-19.
16 Nov, 2021 | 12:47h
Comentário no Twitter
NEW Research—In pts w/ #COVID19 who received IMV for mod-to-sev #ARDS, intravenous immunoglobulins did not improve clinical outcomes at day 28
Phase 3 ICAR trial from Prof Tarek Sharshar & colleagues https://t.co/TBWxngXIPT pic.twitter.com/W2dNBaM1o1
— The Lancet Respiratory Medicine (@LancetRespirMed) November 12, 2021
Revisão | Trombocitopenia trombótica imune induzida por vacina.
16 Nov, 2021 | 12:46hVaccine-induced immune thrombotic thrombocytopenia – The Lancet Haematology
Conteúdos relacionados:
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (vários artigos e fontes sobre o tema)
Comentário no Twitter
NEW Viewpoint by @Erik_Klok_MD, @MPaiMD, Menno Huisman & @ProfMakris discussing the epidemiology, pathophysiology, and optimal diagnostic and therapeutic management of vaccine-induced immune thrombotic thrombocytopenia #VITT #COVID19Vaccine https://t.co/FI4NynwzEn pic.twitter.com/9PbjaioA2T
— The Lancet Haematology (@TheLancetHaem) November 12, 2021
Consenso internacional 2021 sobre ressuscitação cardiopulmonar e cuidado cardiovascular de emergência com recomendações de tratamento.
16 Nov, 2021 | 12:36h2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and Teams; First Aid Task Forces; and the COVID-19 Working Group – Circulation (para versão HTML, clique aqui)
Principais tópicos a saber: International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (CoSTR) – American Heart Association


